Obstructive sleep apnea in adults

SC Veasey, IM Rosen - New England Journal of Medicine, 2019 - Mass Medical Soc
Key Clinical Points Obstructive Sleep Apnea in Adults Obstructive sleep apnea is common
and is an independent risk factor for motor vehicle accidents and cardiovascular disease …

Obstructive sleep apnea: current perspectives

AM Osman, SG Carter, JC Carberry… - Nature and science of …, 2018 - Taylor & Francis
The prevalence of obstructive sleep apnea (OSA) continues to rise. So too do the health,
safety, and economic consequences. On an individual level, the causes and consequences …

[HTML][HTML] European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea

W Randerath, J Verbraecken… - European …, 2021 - Eur Respiratory Soc
Treatment of obstructive sleep apnoea (OSA) in adults is evolving, as new therapies have
been explored and introduced in clinical practice, while other approaches have been refined …

Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015: an American Academy of Sleep …

K Ramar, LC Dort, SG Katz, CJ Lettieri… - Journal of clinical …, 2015 - jcsm.aasm.org
Introduction: Since the previous parameter and review paper publication on oral appliances
(OAs) in 2006, the relevant scientific literature has grown considerably, particularly in …

Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA …

Y Peker, H Glantz, C Eulenburg… - American journal of …, 2016 - atsjournals.org
Rationale: Obstructive sleep apnea (OSA) is common in patients with coronary artery
disease (CAD), many of whom do not report daytime sleepiness. First-line treatment for …

The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial

L Taranto-Montemurro, L Messineo… - American journal of …, 2019 - atsjournals.org
Rationale: There is currently no effective pharmacological treatment for obstructive sleep
apnea (OSA). Recent investigations indicate that drugs with noradrenergic and …

[HTML][HTML] A comprehensive review of obstructive sleep apnea

A Abbasi, SS Gupta, N Sabharwal, V Meghrajani… - Sleep …, 2021 - ncbi.nlm.nih.gov
Obstructive sleep apnea (OSA) is a complex disorder characterized by collapse of the upper
airway during sleep. Downstream effects involve the cardiovascular, pulmonary, and …

CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis

DJ Bratton, T Gaisl, AM Wons, M Kohler - Jama, 2015 - jamanetwork.com
Importance Obstructive sleep apnea is associated with higher levels of blood pressure (BP),
which can lead to increased cardiovascular risk. Objective To compare the association of …

Personalized management approach for OSA

JC Carberry, J Amatoury, DJ Eckert - Chest, 2018 - Elsevier
OSA is a heterogeneous disorder. If left untreated, it has major health, safety, and economic
consequences. In addition to varying levels of impairment in pharyngeal anatomy …

Obstructive sleep apnoea syndrome

P Lévy, M Kohler, WT McNicholas, F Barbé… - Nature reviews Disease …, 2015 - nature.com
Obstructive sleep apnoea syndrome (OSAS) is a common clinical condition in which the
throat narrows or collapses repeatedly during sleep, causing obstructive sleep apnoea …